{"count":220790,"next":"https://panelapp-aus.org/api/v1/activities/?format=json&page=735","previous":"https://panelapp-aus.org/api/v1/activities/?format=json&page=733","results":[{"created":"2022-10-05T17:29:47.782217+11:00","panel_name":"Cholestasis","panel_id":78,"panel_version":"0.236","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: galt has been classified as Green List (High Evidence).","entity_name":"GALT","entity_type":"gene"},{"created":"2022-10-05T17:29:39.891427+11:00","panel_name":"Cholestasis","panel_id":78,"panel_version":"0.236","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: GALT.","entity_name":"GALT","entity_type":"gene"},{"created":"2022-10-05T17:29:23.421158+11:00","panel_name":"Cataract","panel_id":66,"panel_version":"0.345","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: GALT.","entity_name":"GALT","entity_type":"gene"},{"created":"2022-10-05T17:29:09.138961+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.276","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: GALT as ready","entity_name":"GALT","entity_type":"gene"},{"created":"2022-10-05T17:29:09.129695+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.276","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: galt has been classified as Green List (High Evidence).","entity_name":"GALT","entity_type":"gene"},{"created":"2022-10-05T17:29:03.541614+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.276","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: GALT.","entity_name":"GALT","entity_type":"gene"},{"created":"2022-10-05T17:28:50.063675+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.276","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: GALT: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Galactosemia, MIM# 230400; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"GALT","entity_type":"gene"},{"created":"2022-10-05T17:19:56.795390+11:00","panel_name":"Miscellaneous Metabolic Disorders","panel_id":3468,"panel_version":"1.23","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: TAT.","entity_name":"TAT","entity_type":"gene"},{"created":"2022-10-05T17:19:38.866499+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4955","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: TAT.","entity_name":"TAT","entity_type":"gene"},{"created":"2022-10-05T17:19:20.681063+11:00","panel_name":"Palmoplantar Keratoderma and Erythrokeratoderma","panel_id":153,"panel_version":"0.126","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: TAT.","entity_name":"TAT","entity_type":"gene"},{"created":"2022-10-05T17:18:37.757213+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.343","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: TAT.","entity_name":"TAT","entity_type":"gene"},{"created":"2022-10-05T17:18:27.360093+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.276","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: TAT as ready","entity_name":"TAT","entity_type":"gene"},{"created":"2022-10-05T17:18:27.343099+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.276","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: tat has been classified as Green List (High Evidence).","entity_name":"TAT","entity_type":"gene"},{"created":"2022-10-05T17:18:21.248964+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.276","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: TAT.","entity_name":"TAT","entity_type":"gene"},{"created":"2022-10-05T17:18:07.368075+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.276","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: TAT: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Tyrosinaemia, type II, MIM# 276600; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"TAT","entity_type":"gene"},{"created":"2022-10-05T17:15:16.353574+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.276","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PCCB as ready","entity_name":"PCCB","entity_type":"gene"},{"created":"2022-10-05T17:15:16.340294+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.276","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pccb has been classified as Green List (High Evidence).","entity_name":"PCCB","entity_type":"gene"},{"created":"2022-10-05T17:13:29.867422+11:00","panel_name":"Disorders of branched chain amino acid metabolism","panel_id":3929,"panel_version":"1.0","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCB.","entity_name":"PCCB","entity_type":"gene"},{"created":"2022-10-05T17:13:11.683862+11:00","panel_name":"Hyperammonaemia","panel_id":3470,"panel_version":"0.6","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCB.","entity_name":"PCCB","entity_type":"gene"},{"created":"2022-10-05T17:12:15.466304+11:00","panel_name":"Cardiomyopathy_Paediatric","panel_id":3270,"panel_version":"0.134","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCB.","entity_name":"PCCB","entity_type":"gene"},{"created":"2022-10-05T17:11:55.632368+11:00","panel_name":"Stroke","panel_id":3141,"panel_version":"1.7","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCB.","entity_name":"PCCB","entity_type":"gene"},{"created":"2022-10-05T17:11:37.638791+11:00","panel_name":"Dystonia - complex","panel_id":290,"panel_version":"0.217","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCB.","entity_name":"PCCB","entity_type":"gene"},{"created":"2022-10-05T17:11:16.382715+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4955","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCB.","entity_name":"PCCB","entity_type":"gene"},{"created":"2022-10-05T17:10:54.958073+11:00","panel_name":"Regression","panel_id":206,"panel_version":"0.505","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCB.","entity_name":"PCCB","entity_type":"gene"},{"created":"2022-10-05T17:10:27.165470+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.343","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCB.","entity_name":"PCCB","entity_type":"gene"},{"created":"2022-10-05T17:10:14.370210+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1675","user_name":"Zornitza Stark","item_type":"entity","text":"Tag review tag was added to gene: PCCB.","entity_name":"PCCB","entity_type":"gene"},{"created":"2022-10-05T17:09:33.698375+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.276","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PCCB were changed from Propionicacidemia to Propionicacidaemia, MIM#606054","entity_name":"PCCB","entity_type":"gene"},{"created":"2022-10-05T17:09:21.015094+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCB.","entity_name":"PCCB","entity_type":"gene"},{"created":"2022-10-05T17:09:11.068192+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: PCCB: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Propionicacidaemia, MIM#606054; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"PCCB","entity_type":"gene"},{"created":"2022-10-05T17:08:12.348234+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PCCA as ready","entity_name":"PCCA","entity_type":"gene"},{"created":"2022-10-05T17:08:12.340423+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pcca has been classified as Green List (High Evidence).","entity_name":"PCCA","entity_type":"gene"},{"created":"2022-10-05T17:06:10.858022+11:00","panel_name":"Disorders of branched chain amino acid metabolism","panel_id":3929,"panel_version":"1.0","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCA.","entity_name":"PCCA","entity_type":"gene"},{"created":"2022-10-05T17:05:55.400061+11:00","panel_name":"Hyperammonaemia","panel_id":3470,"panel_version":"0.6","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCA.","entity_name":"PCCA","entity_type":"gene"},{"created":"2022-10-05T17:05:36.090912+11:00","panel_name":"Stroke","panel_id":3141,"panel_version":"1.7","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCA.","entity_name":"PCCA","entity_type":"gene"},{"created":"2022-10-05T17:05:20.440384+11:00","panel_name":"Dystonia - complex","panel_id":290,"panel_version":"0.217","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCA.","entity_name":"PCCA","entity_type":"gene"},{"created":"2022-10-05T17:04:42.941143+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4955","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCA.","entity_name":"PCCA","entity_type":"gene"},{"created":"2022-10-05T17:03:50.212404+11:00","panel_name":"Regression","panel_id":206,"panel_version":"0.505","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCA.","entity_name":"PCCA","entity_type":"gene"},{"created":"2022-10-05T17:02:47.293217+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1675","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCA.","entity_name":"PCCA","entity_type":"gene"},{"created":"2022-10-05T17:00:44.351401+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.343","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCA.","entity_name":"PCCA","entity_type":"gene"},{"created":"2022-10-05T17:00:13.279089+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PCCA.","entity_name":"PCCA","entity_type":"gene"},{"created":"2022-10-05T16:49:00.732696+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: PCCA: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Propionic acidaemia, MIM#606054; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"PCCA","entity_type":"gene"},{"created":"2022-10-05T16:40:04.383716+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PCBD1 as ready","entity_name":"PCBD1","entity_type":"gene"},{"created":"2022-10-05T16:40:04.370552+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pcbd1 has been classified as Green List (High Evidence).","entity_name":"PCBD1","entity_type":"gene"},{"created":"2022-10-05T16:39:44.846245+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Tag for review tag was added to gene: PCBD1.","entity_name":"PCBD1","entity_type":"gene"},{"created":"2022-10-05T16:39:34.892604+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: PCBD1: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Hyperphenylalaninemia, BH4-deficient, D , MIM#264070; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"PCBD1","entity_type":"gene"},{"created":"2022-10-05T15:49:18.393427+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: QDPR as ready","entity_name":"QDPR","entity_type":"gene"},{"created":"2022-10-05T15:49:18.383743+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: qdpr has been classified as Green List (High Evidence).","entity_name":"QDPR","entity_type":"gene"},{"created":"2022-10-05T15:44:51.345156+11:00","panel_name":"Dystonia - complex","panel_id":290,"panel_version":"0.217","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: QDPR.","entity_name":"QDPR","entity_type":"gene"},{"created":"2022-10-05T15:44:32.483061+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4955","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: QDPR.","entity_name":"QDPR","entity_type":"gene"},{"created":"2022-10-05T15:44:14.123429+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1675","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: QDPR.","entity_name":"QDPR","entity_type":"gene"},{"created":"2022-10-05T15:43:57.482644+11:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"1.5","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: QDPR.","entity_name":"QDPR","entity_type":"gene"},{"created":"2022-10-05T15:43:24.688998+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: QDPR.","entity_name":"QDPR","entity_type":"gene"},{"created":"2022-10-05T15:43:15.289320+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: QDPR: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Hyperphenylalaninemia, BH4-deficient, C, MIM# 261630; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"QDPR","entity_type":"gene"},{"created":"2022-10-05T15:40:52.614427+11:00","panel_name":"Dystonia - complex","panel_id":290,"panel_version":"0.217","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PTS.","entity_name":"PTS","entity_type":"gene"},{"created":"2022-10-05T15:40:33.356464+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4955","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PTS.","entity_name":"PTS","entity_type":"gene"},{"created":"2022-10-05T15:40:14.265236+11:00","panel_name":"Regression","panel_id":206,"panel_version":"0.505","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PTS.","entity_name":"PTS","entity_type":"gene"},{"created":"2022-10-05T15:39:49.964775+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1675","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PTS.","entity_name":"PTS","entity_type":"gene"},{"created":"2022-10-05T15:39:33.949032+11:00","panel_name":"Neurotransmitter Defects","panel_id":145,"panel_version":"1.5","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PTS.","entity_name":"PTS","entity_type":"gene"},{"created":"2022-10-05T15:39:05.055215+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.343","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PTS.","entity_name":"PTS","entity_type":"gene"},{"created":"2022-10-05T15:38:39.519079+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PTS as ready","entity_name":"PTS","entity_type":"gene"},{"created":"2022-10-05T15:38:39.507477+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pts has been classified as Green List (High Evidence).","entity_name":"PTS","entity_type":"gene"},{"created":"2022-10-05T15:38:31.237992+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PTS.","entity_name":"PTS","entity_type":"gene"},{"created":"2022-10-05T15:31:51.958463+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: PTS: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Hyperphenylalaninemia, BH4-deficient, A, MIM# 261640; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"PTS","entity_type":"gene"},{"created":"2022-10-05T15:28:53.149634+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4955","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PAH as ready","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:28:53.141641+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4955","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pah has been classified as Green List (High Evidence).","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:23:15.622855+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4955","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PAH were changed from  to Phenylketonuria, MIM#261600","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:22:39.726386+11:00","panel_name":"Miscellaneous Metabolic Disorders","panel_id":3468,"panel_version":"1.23","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PAH.","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:22:10.373983+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1675","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PAH as ready","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:22:10.363690+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1675","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pah has been classified as Green List (High Evidence).","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:22:06.564079+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4954","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: PAH was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:21:34.958951+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4953","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: PAH: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Phenylketonuria, MIM#261600; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:21:18.925280+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4953","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PAH.","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:21:05.422449+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1675","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PAH were changed from Phenylketonuria, MIM#261600 to Phenylketonuria, MIM#261600","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:20:31.318355+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1674","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: PAH were changed from  to Phenylketonuria, MIM#261600","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:19:51.687078+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.343","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PAH.","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:19:44.399539+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1673","user_name":"Zornitza Stark","item_type":"entity","text":"Mode of inheritance for gene: PAH was changed from Unknown to BIALLELIC, autosomal or pseudoautosomal","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:19:12.329223+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1672","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: PAH: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Phenylketonuria, MIM#261600; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:18:44.895406+11:00","panel_name":"Genetic Epilepsy","panel_id":202,"panel_version":"0.1672","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PAH.","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:18:00.363522+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: PAH as ready","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:18:00.354136+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: pah has been classified as Green List (High Evidence).","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:17:54.184608+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: PAH.","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:17:44.747296+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: PAH: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Phenylketonuria MIM#261600; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"PAH","entity_type":"gene"},{"created":"2022-10-05T15:13:05.190566+11:00","panel_name":"Hyperammonaemia","panel_id":3470,"panel_version":"0.6","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: ETFB.","entity_name":"ETFB","entity_type":"gene"},{"created":"2022-10-05T15:12:45.284383+11:00","panel_name":"Intellectual disability syndromic and non-syndromic","panel_id":250,"panel_version":"0.4953","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: ETFB.","entity_name":"ETFB","entity_type":"gene"},{"created":"2022-10-05T15:06:51.557279+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.480","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ETFB as ready","entity_name":"ETFB","entity_type":"gene"},{"created":"2022-10-05T15:06:51.548753+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.480","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: etfb has been classified as Red List (Low Evidence).","entity_name":"ETFB","entity_type":"gene"},{"created":"2022-10-05T15:06:44.396736+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.480","user_name":"Zornitza Stark","item_type":"entity","text":"Phenotypes for gene: ETFB were changed from  to Glutaric acidemia IIB, MIM# 231680","entity_name":"ETFB","entity_type":"gene"},{"created":"2022-10-05T15:06:12.697300+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.479","user_name":"Zornitza Stark","item_type":"entity","text":"Classified gene: ETFB as Red List (low evidence)","entity_name":"ETFB","entity_type":"gene"},{"created":"2022-10-05T15:06:12.687379+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.479","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: etfb has been classified as Red List (Low Evidence).","entity_name":"ETFB","entity_type":"gene"},{"created":"2022-10-05T15:05:40.471886+11:00","panel_name":"Callosome","panel_id":205,"panel_version":"0.478","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ETFB: Rating: RED; Mode of pathogenicity: None; Publications: ; Phenotypes: Glutaric acidemia IIB, MIM# 231680; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ETFB","entity_type":"gene"},{"created":"2022-10-05T15:05:02.524392+11:00","panel_name":"Mitochondrial disease","panel_id":203,"panel_version":"0.836","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: ETFB.","entity_name":"ETFB","entity_type":"gene"},{"created":"2022-10-05T14:25:54.723294+11:00","panel_name":"Mendeliome","panel_id":137,"panel_version":"1.343","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: ETFB.","entity_name":"ETFB","entity_type":"gene"},{"created":"2022-10-05T14:25:28.190933+11:00","panel_name":"Fatty Acid Oxidation Defects","panel_id":103,"panel_version":"1.8","user_name":"Zornitza Stark","item_type":"entity","text":"Tag treatable tag was added to gene: ETFB.","entity_name":"ETFB","entity_type":"gene"},{"created":"2022-10-05T14:25:19.178776+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ETFB as ready","entity_name":"ETFB","entity_type":"gene"},{"created":"2022-10-05T14:25:19.170207+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: etfb has been classified as Green List (High Evidence).","entity_name":"ETFB","entity_type":"gene"},{"created":"2022-10-05T14:24:40.141902+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Tag for review tag was added to gene: ETFB.","entity_name":"ETFB","entity_type":"gene"},{"created":"2022-10-05T14:24:28.544009+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"reviewed gene: ETFB: Rating: GREEN; Mode of pathogenicity: None; Publications: ; Phenotypes: Glutaric acidemia IIB, MIM# 231680; Mode of inheritance: BIALLELIC, autosomal or pseudoautosomal","entity_name":"ETFB","entity_type":"gene"},{"created":"2022-10-05T14:22:05.110579+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Marked gene: ETFA as ready","entity_name":"ETFA","entity_type":"gene"},{"created":"2022-10-05T14:22:05.081895+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Gene: etfa has been classified as Green List (High Evidence).","entity_name":"ETFA","entity_type":"gene"},{"created":"2022-10-05T14:22:00.636404+11:00","panel_name":"gNBS","panel_id":3931,"panel_version":"0.275","user_name":"Zornitza Stark","item_type":"entity","text":"Publications for gene: ETFA were set to ","entity_name":"ETFA","entity_type":"gene"}]}